According to a national survey of 800 primary care physicians conducted by Pri-Med Institute, Boston, almost three-quarters of physicians who participated said that commercial support of CME by pharmaceutical companies is a good thing. Just 8 percent said they were less likely to attend a CME program that is underwritten by pharma funds, and only 10 percent viewed industry support as “negative.” Regardless of their feelings, an overwhelming 86 percent said whether a program is supported by
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments